Virus therapy aims to boost chemo in tough pancreatic cancer
Disease control
Not yet recruiting
This trial tests whether a virus called VCN-01, given more frequently, is safe and tolerable when combined with standard chemotherapy (nab-paclitaxel and gemcitabine) for people with newly diagnosed stage IV pancreatic cancer that has spread. Participants receive up to three dose…
Phase: PHASE1, PHASE2 • Sponsor: Theriva Biologics SL • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC